Drug allergy laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]

Drug Allergy
Home
Patient Information
Overview
Classification
Pathophysiology
Causes
Differentiating Drug allergy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Drug allergy laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Drug allergy laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Drug allergy laboratory findings
CDC on Drug allergy laboratory findings
Drug allergy laboratory findings in the news
Blogs on Drug allergy laboratory findings
Directions to Hospitals Treating Drug allergy
Risk calculators and risk factors for Drug allergy laboratory findings

Overview

Drug allergy and its associated conditions is primarily a clinical diagnosis based on the patient history, and through physical exam. Certain laboratory findings may be seen during the acute phase of the reaction, but are not always specific. Skin testing and biopsies can be performed when there is not a clear diagnosis.

Laboratory Findings

• Erythrocyte sedimentation rate (ESR) may be increased.
• White blood cell (WBC) may be increased.
• Urine eosinophils may be increased, especially in cases of allergic interstitial nephritis.
• Blood eosinophils may be increased, especially in cases of drug induced TEN.
• Liver function tests (LFT)'s may be increased.
• Elevations in tryptase may be seen detected in serum or plasma within several hours after an acute allergic event, and is consistent with anaphylaxis.
• Histamine levels may be elevated after an acute reaction, but is unreliable for diagnosis.

Other Tests

• Skin testing for drug-specific IgE. Only for type I allergic reactions.
• In-vitro tests for immediate drug reactions are available, but are largely considered investigational.
• Patch testing to test for a type IV reaction where drugs are mixed into petrolatum and applied to the skin for 48 hours. This test is useful in evaluating patients with maculopapular exanthema, acute generalized exanthematous pustulosis, and flexular exanthema. It is not to be used in patients with a history of Stevens-johnson syndrome or toxic epidermal necrolysis.
• Intradermal testing with delayed readout is more sensitive than a patch test, and involves injection of a small amount of the allergen dissolved in water, under the skin. A prick test should be done beforehand, and the concentration used should be non-irritating.
• Skin biopsy may be useful to distinguish between Stevens-johnson syndrome and toxic epidermal necrolysis, and also to rule out other conditions on the differential diagnosis list.